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For many years specific immune responses have been generally classified  as 
to whether they are mediated by humoral antibodies or by sensitized lymphoid 
cells.  More recently has come the realization that on the cellular level these 
two types of responses are mediated by two major classes of lymphocytes, the 
bursal-equivalent  or  B  cells  being  the  precursors  of  antibody-forming cells 
and T  cells  being  responsible for  cell-mediated reactions  (1-5).  Immune re- 
sponses within each of these major cell populations are in turn generally char- 
acterized  by  extensive heterogeneity (in  terms  of  the  products  or  activities 
eventually measured);  a  clearer  understanding of  the  cellular basis  for  this 
heterogeneity is one of the major goals of current research. 
Examination of the  cellular heterogeneity within the B-cell  pool following 
antigenic stimulation has been greatly facilitated by the availability of satis- 
factory techniques for the enumeration and study of isolated antibody-form- 
ing cells  (6-9).  Such studies have in general indicated that the specificity and 
immunoglobulin class of the product of an individual antibody-producing cell 
is highly restricted (10-14). 
The absence of analogous single cell techniques for assaying the many activi- 
ties generated within the T-cell pool following antigenic stimulation continues 
to restrict our ability to understand the cellular basis for this functional diver- 
sity. Until such methodology is available one can only approach the problem 
indirectly by examination and quantitation of the activities of different popula- 
tions of T  cells. If the quantitative analysis of the activities measured in these 
populations indicates a dissociation of activities, then it is reasonable to postu- 
late that different cells mediate the activities in question. Such an hypothesis 
is then supported (indirectly) by any additional examples of situations in which 
these activities dissociate from each other. 
In the present study we have investigated some of the physical and biological 
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properties  of  the  ceils  involved  in  two  different  assays  of  cell-mediated  im- 
munity generated  by mice in response  to  the  antigenic stimulation  of a  tumor 
allograft.  The  effector activities  assayed  were  the  cell-mediated lysis of radio- 
labeled target cells and the antigen-stimulated inhibition of macrophage migra- 
tion. The results  to  be presented  suggest  that  separable  populations  of T  cells 
are  involved  in  mediating  these  two  reactions.  The  subpopulations  have  (a) 
distinctive tissue  distributions  in  appropriately  immunized  animals,  (3)  differ- 
ential  migratory  properties  upon  adoptive  transfer  into  irradiated  syngeneic 
hosts,  and  (c)  distinctive  activity  profiles  after  1  g  velocity  sedimentation. 
Additional  experiments  utilizing velocity sedimentation  of normal  spleen  cells 
before their in vitro sensitization  to  alloantigens  further  suggest  that  the pro- 
genitors of these T-effector cells may be different. 
Materials  and Methods 
Miee.--8-12-wk old male mice of the strains BALB/c (H-2a), DBA/2 (H-2d), and C57BL/ 
Blue (H-2  b) were obtained  from the Imperial Cancer  Research Fund  breeding unit at Mill 
Hill, London. 
Irradiation.--Mice  were irradiated  by gamma rays from a  Co  ~° source  with a  total of 850 
rads at a  dose rate of 24 rads/min. When irradiated cells were needed, cell suspensions  were 
kept chilled  on ice and exposed  to 1,500 rads,  at a dose rate of 200 fads/rain. 
Cell  Preparation.--Spleen,  mesenteric  lymph  node  (MLN), 1 or  peripheral  lymph  node 
(PLN,  cervical, submandibular,  axillary and  inguinal)  cells were prepared  by  teasing  the 
respective tissues  apart in ice-cold phosphate-buffered saline, pH 7.2 (PBS). Large fragments 
were allowed to settle out and the supernatant suspensions  were centrifuged at 200 g for 10 rain 
at 4°C.  Peripheral blood  was collected into heparinized PBS  (10 U/ml) and  the suspension 
centrifuged at 200 g for 10 rain at 4°C. Red cells in all of the above suspensions  were lysed with 
Tris-buffered ammonium chloride, according to the method described by Boyle (15). Follow- 
ing this treatment the suspensions  were washed  three times in cold PBS.  Peritoneal macro- 
phages were obtained from C57BL mice injected intraperitoneally (i.p.)  2-4 days earlier with 
0.25 ml complete Freund's adjuvant (16). Before use, all cell suspensions  were resuspended to 
the desired  concentration  in  Dulbecco's modified  Eagle's medium  (with added  glutamine, 
penicillin, and streptomycin) supplemented with 10% heat-inactivated fetal calf serum (DF10). 
All cell concentrations refer to viable nucleated cells, as determined by trypan blue dye exclu- 
sion. 
Preparation,  Specificity,  and  Use  of  Rabbit  Antimouse  Brain-Associated  0 Serum  (Anti- 
BAO).--Anfi-BAO serum was prepared as described by Golub (17). The antiserum  was heat- 
inactivated at 56°C for 30 rain and was then absorbed twice for 30 min at room temperature 
with an equal volume of packed  BALB/c liver suspension;  finally it was filtered through a 
Millipore filter (0.45 #) and stored at -20°C. 
Cells to be treated with the anti-BA0 serum were incubated  for 90 min at 4°C at  a con- 
centration of l0  T  cells/ml in a  1/15 dilution of the antiserum diluted in DF10. Control suspen- 
sions were incubated in DF10 alone. The cells were then washed in DF10, centrifuged at 200 g 
1 Abbreviations  used in this  paper:  anti-BA0,  rabbit  antimouse  brain-associated  0;  BSA, 
bovine serum albumin; con A, concanavalin A; DF10, Dulbecco's modified  Eagle's medium + 
10%  fetal calf serum;  DNP-POL,  dinitrophenylated  polymerized  flagellin; EBSS,  Earle's 
balanced salt solution; LPS, E. Coli lipopolysaccharide; MLN, mesenteric lymph nodes; PBL, 
peripheral  blood  leucocytes;  PBS,  phosphate-buffered  saline;  PHA,  phytohemagglutinin; 
PLN, peripheral lymph nodes; SMAF, specific macrophage-arming factor. ROBERT  E.  TIGELAAR  AND  R.  M.  GORCZYNSKI  269 
for 5 rain at 4°C and resuspended to the same volume in either DF10 or fresh frozen guinea 
pig serum (1/10 in DF10) which had been previously absorbed twice with 10% packed mouse 
thymocytes. The suspensions were incubated at 37°C for 45 rain in an atmosphere of humidi- 
fied 10% CO2 in air, washed twice, and then resuspended to the desired concentration in DF10. 
Detailed specificity tests of  this antiserum have been previously described  (18).  Briefly, 
three types of tests have been employed. The serum was examined for its cytotoxicity  (de- 
termined by trypan blue dye exclusion) toward normal mouse thymus and PLN cells.  In the 
absence of complement the serum was not toxic for these cells, and in the presence of comple- 
ment killed 100% of thymocytes and 70% of PLN ceils,  this data being in good agreement 
with previously published percentages of T  cells in such suspensions (19). A second test of the 
functional specificity of this antiserum toward T  cells examined its ability to suppress the 
enhanced protein synthesis (measured  by incorporation of [SH]leucine) seen in suspensions of 
spleen cells cultured for 18-24 h  in leucine-free medium with either PHA or Escherichia coli 
lipopolysaccharide  (LPS), T  and B  cell mitogens, respectively (20).  Pretreatment of spleen 
cells with the anti-BA0 serum and complement abolished the PHA response, but left the LPS 
response unaffected. The third test employed was  the effect of antiserum and complement 
pretreatment of cells on their ability to subsequently make antibody-forming cells in vitro to 
sheep erythrocytes (SRBC)  and dinitrophenylated polymerized flagellin (DNP-POL).  Such 
pretreatment abolished the SRBC response but had no effect on the response to DNP-POL, 
the latter presumably being a  T-cell independent response  (21).  Furthermore,  the depleted 
SRBC response of the treated spleen cells was fully reconstituted with small numbers of edu- 
cated thymocytes (obtained from spleens of mice irradiated with 850 rads 7 days earlier and 
then immediately given 108 SRBC and 108 syngeneic thymocytes), but was not reconstituted 
with mature B  cells (obtained from those lymphocytes of adult mouse bone marrow which 
sediment by velocity sedimentation at 2.7-3.3 mm/h (18, 22, 23). 
Tumor  Cell  Lines.--P815X2,  an ascites  tumor  of  mast cells derived from  DBA/2  mice 
(24), was obtained from Dr, J. C. Cerottini and was maintained in vivo by serial weekly i.p. 
passage in DBA/2 mice. This cell line was also maintained in vitro by serial passage in DF10 
at 37°C  in a  humidified atmosphere of 10% CO2. Cell concentration was kept at  <2  X  10  s 
cells/ml (5 ml of cell suspension in 60 x 15-ram tissue culture dishes); under these conditions 
a doubling time of 10-12 h was routinely seen and the harvested cells provided excellent repro- 
ducible targets for the cytotoxicity assay described below. Every 12-18 wk aseptically aspi- 
rated ascitic fluid from tumor-bearing mice was used to derive a  fresh tissue culture cell line. 
In some experiments the C57BL ascites tumor EL-4 (25) was used as a target cell. This tumor 
was the gift of Dr. J. Martin and was maintained by weekly serial passage in C57BL mice. 
In Vivo Immunization.--P815X2 cells were obtained from the peritoneal cavity of tumor- 
bearing DBA-2 mice by collecting an aspirate into PBS containing 10 U/ml heparin. The 
cells were washed three times and then counted. Ten million viable tumor cells (in 0.5 ml) 
were then injected i.p. into each of a  number of C57BL mice, care being taken to avoid sub- 
cutaneous inoculation. 
In Vitro Immunization.--Seven million normal unfractionated or velocity-sedimented (see 
below) C57BL spleen cells were cultured in the presence of 3  X  106 irradiated  (1,500  rads) 
BALB/c spleen cells in fiat-bottom plastic tubes (12 mm diameter) in 4 ml of DF10 containing 
5 X  10  -5 M 2-mercaptoethanol. Multiple identical culture vessels were set up for each fraction 
to be tested, the exact number depending on the numbers of cells available from that fraction. 
After 5 days incubation in a  stationary position at 37°C  in a humidified atmosphere of 10% 
CO2 in air, the multiple cultures were harvested (all the cultures from a  given fraction were 
pooled), washed once, resuspended to appropriate volumes with DF10, and the aliquots tested 
in both the cytotoxicity assay and the macrophage migration inhibition assay (see Results). 
Velocity Sedimentation Cell Separation.--This technique, which separates cells primarily on 
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chambers, 11.0 em in diameter (Aimer Glass Co., London, England) were used in all experi- 
ments. Briefly, 3  X  l0  s nucleated spleen cells (or 2  ×  10  s PLN cells) were suspended in 30 ml 
of 0.3% bovine serum albumin (BSA) in Earle's balanced salt solution (EBSS) and separated 
at unit gravity for 3 or 4 h at 4°C through a buffered step gradient of BSA in EBSS ranging 
in concentration from 0.6% to 2.0%. 30-ml fractions were collected, the ceils in each fraction 
counted, and the suspensions centrifuged at 200 g for 10 min at 4°C.  Appropriate fractions 
were pooled (see Results), washed again, recounted, and resuspended to appropriate volumes 
in DF10. Yields were generally 75-90% of the cells initially loaded. The osmolarity of the EBSS 
and  Dulbecco's modified Eagle's medium used  throughout these experiments was approxi- 
mately 270 mOsmol/liter and 370 mOsmol/liter, respectively. 
Cytoloxicity'Assay.--Five-ten million P815X2 ceils were radiolabeled in 1.0 ml DF10 con- 
taining 50/zc SlCr  (as sodium chromate, Radiochemical Centre, Amersham, England) for 40 
rain at 37°C  in 10% CO2 in air. After incubation the suspension was washed four times in 
25 ml of room temperature Dulbecco's medium containing 20% fetal calf serum by centrifuga- 
tion at room temperature for 5 rain at 200 g. These target cells were then resuspended in DFlo 
to 5  X  105 eells/ml. Various numbers of viable immune cells in 1.0 ml DF10 were then mixed 
with 5  X  104 51Cr-labeled  P815X2 cells (0.1  ml) in 16-mm tissue culture wells.  Any  group 
was always assayed in triplicate. After incubation on a  rocking platform (6 cycles/min)  at 
37°C in a  humidified atmosphere of 10% COs,  the contents of the wells were harvested,  cen- 
trifuged at 1,000 g for 10 min, and the supernatant fluid counted in a well-type gamma counter. 
Controls included target cells incubated with either medium alone (background) or with 5% 
detergent  (maximum releasable 51Cr). Detergent release was routinely 75-80% of the  total 
51Cr in the suspension. Several early experiments also utilized various numbers of normal cells 
from spleen, MLN, and PLN incubated with target cells. As was noted by Brunner et al.  (26), 
the release in the presence of normal lymphocytes was not significantly different from  the 
release in the presence of medium alone, and thus for convenience the latter control was  rou- 
tinely used for determination of background 51Cr release. This background varied from 8-17% 
(mean  12.8%)  during  the  several months when  these  experiments were  being  performed. 
Specific '~ICr  release was calculated according to the formula : specific 51Crrelease (%) =  100 X 
(experimental-background/maximum releasable  51Cr-background).  Data  points in  text  are 
means ~  1 standard error of the mean (SEM) of triplicate determinations. 
Macrophage Migration Inhibition Assay.--A  modification of earlier techniques (27),  which 
has been found to be suitable for use in mice, has been described previously in some detail (16). 
Normal mouse macrophages were obtained as peritoneal exudates from C57BL mice injected 
2-4 days earlier with 0.25  ml complete Freund's adjuvant, washed, and resuspended  to  10  s 
cells/ml (in DF10). 0.04 ml of this suspension was then mixed with 0.04 ml of immune or normal 
C57BL cell suspension (see  Results for specific  cell number) and 0.02  ml of either irradiated 
(1,500 rads) BALB/c spleen cells as specific antigen or irradiated C57BL spleen ceils as controls 
(each at 10S/ml).  Capillary tubes (25/zl) were filled with the suspension, flame sealed at one 
end, and spun at 200 g for 5 min at 4°C. The tubes were cut at the cell-fluid interlace and the 
stubs fixed  with a  drop of silicone grease in 35-mm tissue culture dishes; 2 ml of DF10 were 
then added to each dish and the dishes incubated at 37°C in 10% COs for 18-24 h. The area 
of migration was qnantitated using a  dissecting microscope fitted with an eyepiece graticule. 
The percent migration inhibition was calculated as: 
100  X  ~1  --  mean  migration in presence of  specific  antigen) 
\  mean migration in  absence  of  specific  antigen/ 
Four capillaries were used for each group; data is expressed as mean %  migration inhibition 
95% confidence limits. 
RESULTS 
Tissue  Distribution  of  Cytotoxic  Lymphocytes  at  Various  Times  After  Im- 
munization.--C57BL  mice  were  immunized  by i.p.  inoculation  of  107  P815X2 ROBERT  E.  TIGELAAR AND  R.  M.  GORCZYNSKI  271 
cells. At various times thereafter  groups  of mice were  sacrificed  and cell sus- 
pensions of various tissues prepared.  Any single experiment involved pools of 
cells harvested  from  at  least  four mice.  Separate  suspensions were  prepared 
from  MLN  and  PLN  (i.e.  axillary,  cervical,  submandibular  and  inguinal). 
These  suspensions, as well as suspensions of spleen cells and peripheral blood 
leucocytes  (PBL)  were  then  tested  for  their  capacity  to  lyse  51Cr-labeled 
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FIG. 1.  Cytotoxicity for 51Cr-labeled P815X2 targets of various lymphoid tissues harvested 
from  C57BL  mice  at  different  times  after  i.p.  inoculation of  107  allogeneic  tumor  cells 
(P815X2).  Tissues examined were PLN (A), PBL (©), MLN (V1), and spleen (Q). All wells 
contained 5 X  104 ~lCr-labeled P815X2 cells and the indicated number of viable immune cells; 
incubation was carried out for 4 h at 37°C on a rocking platform. In any single experiment, 
each dilution of immune cells was plated in triplicate and the results calculated as mean % 
specific SlCr release (see Materials and Methods). The data shown for day 30 are results from 
a single experiment; that for days 8,  12, and 21 are means ±  1 SEM calculated from data 
pooled from at least three separate experiments for each of the indicated points. 272  SUBPOPULATIONS  OF  ACTIVATED  MURINE  T  LYMPHOCYTES 
Several observations warrant comment. The activity of any population was 
a  linear function of the logarithm of the number of attacking cells present in 
the incubation mixture, an observation noted by several previous investigators 
(28-30). Spleen, MLN, and PBL cells showed an obvious increase in  activity 
between day 8 and day 12, indicated both by a shift in the dilution curves to 
the left as well as by an increase in the slope of the dilution curves (28). The 
levels of cytotoxic activity in  these three tissues remained  at relatively high 
levels through day 21, although PBL seemed to have decreased somewhat by 
this  time.  By day 30 there was  a  decrease in  the cytotoxic activity of these 
three tissues.  These results  are very similar  to  those previously reported by 
Brunner et al  (26). 
In contrast to the substantial levels of cytotoxicity observed in spleen, MLN, 
and  PBL,  PLN  cells  displayed  very little  cytotoxic activity  at  any  of  the 
times examined. Very low levers were seen on day 8  (11.5% lysis at a  300:1 
ratio)  and  this  activity showed no  tendency to  increase  with  time after im- 
munization. Although  accurate quantitation  of the  differences between PLN 
and  the other tissues is difficult because of the obvious nonparallelism of the 
dilution curves, nevertheless one can estimate that at any of the times tested 
PLN cells were approximately only ~/i0th  as active as spleen, MLN,  or even 
PBL cells. 
These results suggested a marked deficiency in cytotoxic lymphocytes in the 
peripheral lymph nodes of mice immunized i.p.  with a  tumor allograft, when 
such  cells were  compared  to  the  other  tissues  tested.  However an  alternate 
explanation  for  these  observations  was  that  in  addition  to  containing  sub- 
stantial  numbers  of cytotoxic lymphocytes, PLN  suspensions  also  contained 
cells and/or substances which directly suppressed  the expression of this cyto- 
toxicity. If such suppressive activity were present in PLN suspensions, it might 
be possible for these suspensions to directly inhibit the cytotoxic activity  of 
populations known to be active. Direct evidence for such suppressive activity 
in  PLN  suspensions  was  sought  by mixing  12  day  immune  PLN  cells  with 
either 12 day immune spleen, MLN or PBL cells for 1 h at 37°C before testing 
for cytotoxic activity. Control suspensions of unmixed populations were also 
incubated before testing. Table I demonstrates that under the conditions tested, 
no such suppressive activity was found. The cytotoxic activity of either 2.5  X 
106 PBL or 5  X  106 spleen or MLN cells was identical whether preincubated 
and tested in medium alone or in medium  containing 5 X  106 immune  PLN 
ceils. 
It seemed likely that  the route of administration of the immunizing tumor 
allograft  was  a  major  factor in  determining  the  relative levels of cytotoxic 
activity observed. In order to test this more directly, C57BL mice were inocu- 
lated in several subcutaneous sites (instead of i.p.) with a total of 107 P815X2 
cells.  14  days  later  suspensions  of PBL,  spleen,  MLN,  and  PLN cells from 
these mice were tested in the cytotoxicity assay. The results of this experiment ROBERT  E. TIGELAAR  AND  R. M.  GORCZYNSKI  273 
TABLE  I 
Lack  of Demonstrable Suppressive  Activity in  12-Day  Immune PLN  Cells on the Cytotoxic 
Activity of 12-Day Immune PBL, MLN, or Spleen  Cells 
Cell source 
%Specific 51XCrRelease* 
Alone  With added PLN~: 
PLN (100:1)§  5.5  4-  0.8  -- 
PBL (50:1)  26.5  4-  0.8  27  4-  0.3 
MLN (100:1)  37  4-  1.2  38  4-  1.5 
Spleen (100:1)  53  4-  1.3  55  4-  0.6 
* Calculated  as described  in  Materials and  Methods.  Numbers are means of triplicate 
determinations 4- SEM. 
:~ Immune PLN cells were preincubated with the population to be tested for 1 h  (37°C) 
before incubation with target cells. Each well contained  5 X 106 (100:1) PLN cells in addition 
to the indicated number (see §) of either PBL, MLN, or spleen cells. 
§ Effector:target cell ratio; all wells contained  5 X  104 51Cr-labeled P815 cells. 
showed  that  after  this  route  of  immunization,  PBL,  spleen,  and  PLN  cells 
showed substantial  levels of cytotoxicity  (approximately 40 %, 70 %, and 30 % 
specific lysis, respectively,  at ratios of 200:1)  while now  MLN  cells were vir- 
tually inactive (only 8 %  lysis at a  200:1  ratio). 
Taken together,  the above results suggested that both PLN and MLN could 
generate  cytotoxic  activity  but  that  proximity  of  antigen  was  crucial  in  this 
generation.  Distal,  presumably nondraining  lymph nodes would neither gener- 
ate  nor  contain  substantial  cytotoxic  activity;  on  the  other  hand  PBL  (and 
spleen)  contained  substantial  cytotoxic  activity  irrespective  of  the  route  of 
antigen  administration.  This discrepancy  between proximal  lymph nodes  and 
PBL  on  the  one  hand  and  nondraining  lymph  nodes  on  the  other  suggested 
that cytotoxic lymphocytes were not equally distributed  throughout  the recir- 
culating pool (31) ; their presence in PBL did not insure access into lymph node 
tissue. 
Other  investigators  using  similar models for generating  and  assaying  cyto- 
toxic activity to tumor allografts have examined in some detail  the specificity 
of target  cell lysis  (30,  32-34).  They have concluded  that  lysis of target  cells 
other than the one used for immunization can for the greatest part be explained 
by sharing  of serologically  defined  H-2  antigenic  specificities.  Detailed  speci- 
ficity  tests  were  not  performed  in  this  study.  Nevertheless,  two  experiments 
were performed in which the specificity of the cytotoxicity assay was examined. 
14-day C57BL anti-P815X2  immune spleen cells were tested for their capacity 
to  lyse either  ~lCr-labeled  P815X2  cells  or  51Cr-labeled  EL-4  cells,  a  C57BL 
ascites  tumor.  Additional  wells  were  set up  with  the  immune  C57BL  spleen 
cells,  51Cr-labeled  EL-4  cells,  as well  as unlabeled  P815X2  cells.  Five million 
immune spleen cells were able to release 42 %  of the  51Cr when incubated  with 
5  X  104 labeled  P815X2  cells,  but  caused  only  1%  specific  lysis  of 5  X  104 274  SUBPOPULATIONS  OF  ACTIVATED  MURINE  T  LYMPHOCYTES 
labeled EL-4 cells and only 1.5 % specific lysis from 5 )<  104 labeled EL-4 ceils 
in the presence of 5 )< 104 unlabeled P815X2 cells. This absence of "bystander" 
lysis had also been observed by other investigators (30,  32, 33). 
Comparison of Immune Spleen  and PLN Cells in  Tests of Cytotoxicity  and 
Macrophage Migration  Inhibition.--Having  demonstrated  that  PLN  cells  of 
i.p.  immunized mice were markedly deficient in cytotoxic lymphocytes com- 
pared to other tissues, it was of interest to determine whether this deficiency 
would also be apparent it one used another assay for cell-mediated immunity, 
namely, the ability of sensitized lymphocytes in the presence of specific anti- 
gen to inhibit the migration of mouse peritoneal macrophages. This assay has 
previously been used as a measure of cell-mediated immunity of mice to both 
alloantigens (16) and Maloney sarcoma virus (35, 36). Accordingly, suspensions 
of spleen  and  PLN cells were prepared from C57BL mice  14 days after i.p. 
inoculation with  10  r P815X2  cells.  Aliquots of these cells were then tested in 
parallel for both  cytotoxicity and  capacity to inhibit macrophage migration. 
These results are shown in Fig. 2. As in previous experiments spleen cells were 
found to be vastly superior to equal numbers of PLN cells in their capacity to 
lyse 51Cr-labeled P815X2 cells (panel a). On the other hand, as shown in panel 
b, immune PLN cells were at least as active on a cell for cell basis as immune 
spleen cells in  the  assay of macrophage migration inhibition.  It  can be seen 
that in the presence of specific antigen (irradiated BALB/c spleen cells)  the  % 
migration inhibition with  either immune population was  a  linear function of 
the number of immune cells in  the capillary tube.  In  the absence of specific 
antigen neither population showed significant migration inhibition when com- 
pared to the migration of macrophages mixed with normal C57BL spleen cells 
either with  or without specific antigen.  (These latter  controls were included 
in  this  and  all  subsequent  experiments  and  are  always  represented  by  0% 
migration inhibition; i.e., all experimental groups were compared to this figure 
in  calculating the data.)  Although irradiated  BALB/c spleen cells  were rou- 
tinely used  as  the  specific antigen  in  this  assay,  similar  quantitative  results 
have been found whenever irradiated DBA/2 spleen cells were used. 
These  results  showed  that  although  immune  PLN  cells  were  markedly 
deficient  in  cytotoxlc lymphocytes when  compared  to  immune  spleen  cells, 
they were not at all inferior to spleen cells when tested in the migration inhibi- 
tion assay. That is, while substantial amounts  of both  activities were present 
in immune spleen cell suspensions, immune PLN cells had significant amounts 
only of migration inhibitmn activity. This dissociation was the first suggestion 
that different cells might be mediating these two effector activities. 
Adoptive  Transfer of Immune Spleen Cells into Lethally  Irradiated  Syngeneic 
Recipients.--The experiments illustrated in Fig. 2 suggested to us that different 
cells might  be  mediating  cytotoxicity and  macrophage  migration  inhibition. 
If this hypothesis was correct, then one might anticipate that upon adoptive 
transfer (into syngeneic recipients) of an immune population known to contain ROBERT E.  TIGELAAR AND  R.  M.  GORCZYNSKI  275 
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Fla. 2. Quantitative comparison of spleen (0) and PLN (A) cells from C57BL mice 14 
days after i.p. immunization with 107 P815X2 cells in two in vitro assays of celi-mediated im- 
munity. Panel a illustrates  the cytotoxicity of these immune cells for StCr-labeled P815X2 
cells. Test performed and results calculated as described in Materials and Methods. Panel b 
shows the data obtained in parallel in a test of macrophage migration inhibition. Closed sym- 
bols show the %  migration inhibition of 108 C57BL macrophages seen with  the indicated 
numbers of immune cells in the presence of specific  antigen (4 >( l0  s irradiated BALB/c spIeen 
cells), the open symbols that seen in the absence of antigen (4 X 105 irradiated C57BL spleen 
cells). Data points represent the arithmetic means, with 95% confidence  limits, of quadrupli- 
cate determinations. 
substantial amounts of both effector  activities these  effector  activities might 
display different patterns  of  localization in  recipient  lymphoid  tissues.  The 
next series of experiments were performed to test more explicitly this hypothe- 
sis.  Spleen cell suspensions were prepared  from  C57BL  mice immunized i.p. 
14  days  earlier.  These  cells  were  then  injected  intravenously into  normal 
C57BL recipients (1@ cells/recipient) who had 2 h  previously been exposed to 
850 rads.  24-h later these mice were sacrificed and suspensions prepared from 276  SUBPOPULATIONS  OF  ACTIVATED  MURINE  T  LYMPHOCYTES 
either the pooled spleens or pooled peripheral lymph nodes. Viable nucleated 
cell counts revealed that the yield of spleen cells was approximately 12 X  10  ~ 
cells/recipient  and  of  PLN  cells  approximately  2.5  )<  10 G cells/recipient. 
These suspensions  were then each  tested in  both  the  cytotoxicity assay and 
migration inhibition assay; the results are depicted in Fig. 3. The upper panel 
shows that on a  cell for cell basis the spleen seeking (SpS) cells were approxi- 
mately  10  times  as  active as  the  lymph  node  seeking  (LNS)  cells  in  lysing 
mCr-labeled P815X2  cells.  In  contrast to these findings,  when the cells were 
tested for their capacity to inhibit macrophage migration  (lower panel),  the 
LNS cells  were found to be at least twice as active on a  cell for cell basis as 
the SpS population. These results were confirmed on two additional occasions. 
An  aliquot of the original  14 day immune spleen cell suspension had been 
labeled  in  vitro  with  51CR. These cells were  similarly injected into  lethally 
irradiated syngeneic recipients; 24 h later the mice were sacrificed and various 
tissues removed and counted in a gamma counter to determine the  % localiza- 
tion of the injected cells. The mean % localization (~ 1 SEM)  was determined 
for the following tissues: spleen, 42 ±  3.6%; PLN, 5.4 ~  1.2%; MLN, 6.5  ± 
1.1%; liver, 40 :i:  0.9%; lung, 3.0 ±  0.5 %; and small intestine, 2.6  ±  0.7%. 
This homing pattern of immune spleen cells is in good  agreement  with  previ- 
ously published  studies  (37,  38)  of normal  spleen  cells,  and  argues  that  the 
distinctive migration patterns  of effector activities described  above was  not 
due to abnormal preparation or handling of the cell suspensions. 
The results of these experiments showed that while cytotoxic cells displayed 
a  decided preference to migrate to the spleens rather than to the PLN of ir- 
radiated syngeneic recipients, the cells capable of effecting macrophage migra- 
tion inhibition were much more able  to localize in or migrate to PLN.  Such 
findings support the hypothesis that the cells mediating these two reactions are 
not identical. 
Effect  of Anti-T-Cell Antiserum  Pretreatment  of  Immune  Cells  on  Cytotoxic 
and  Macrophage  Migration  Inhibition  Activities.--Several  investigators  have 
concluded that  the  cytotoxicity observed in  a  short  term  mCr release  assay 
with cells immunized to alloantigens either in vivo (33,  39) or in vitro (40)  is 
due principally to T-cell-mediated lysis,  although other cell types have been 
implicated  (41-44).  Similarly,  the  cell  type  which  mediates  antigen-specific 
macrophage  migration  inhibition has  characteristics  of a  T  cell  in  both  the 
guinea pig  (45-47)  and  the mouse  (16,  35,  36).  Nevertheless, because of our 
observations suggesting that different cells might be mediating these reactions, 
we felt it was important  to determine the derivation of the effector cells  in- 
volved in our particular assays. This was studied by investigating the effects 
of in vitro pretreatment of immune cells with  a rabbit antimouse brain  anti- 
serum  (21).  The  specificity tests  performed  with  this  antiserum  have  been 
described in detail elsewhere (18) and are summarized in Materials and Meth- 
ods. By all criteria examined this antiserum in the presence of guinea pig corn- ROBERT  E.  TIGELAAR  AND  R.  M.  GORCZYNSKI  277 
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FIo. 3.  Adoptive transfer of 14-day immune spleen cells into lethally irradiated syngeneic 
recipients: quantitative comparison of the cytotoxic and macrophage migration inhibition ac- 
tivities found in cells recovered from recipient spleens (O) and PLN  (&) 24 h  later. 10  s im- 
mune spleen cells from mice immunized 14 days before with 107 allogeneic tumor cells were 
transferred into each of several C57BL recipients exposed 2 h previously to 850 rads. 24 hours 
later the animals were sacrificed and suspensions prepared from spkens and PLN.  Panel a 
illustrates the capacity of various numbers of such cells to lyse 51Cr-labeled  P815X2 cells (5 X 
104 targets/well). Results expressed as means (4- 1 SEM) of triplicate determinations. Panel b 
shows the results of the parallel test of various numbers of such cells to inhibit macrophage 
migration. Tubes contained  106 macrophages, the indicated numbers of immune cells,  and 
either 4  )< 105 irradiated BALB/c spleen cells (closed  symbols) or 4  )< 10  ~ irradiated C57BL 
spleen cells (open symbols). Data points are means (±95% confidence limits) of quadruplicate 
determinations assayed after 18 h. 278  SUBPOPULATIONS  OF  ACTIVATED  MURINE  T  LYMPHOCYTES 
plement  is  cytotoxic only for T  lymphocytes.  Table  II shows  the  results  of 
pretreatment  of 14 day immune spleen cells with  this antiserum  either in  the 
presence or absence of guinea pig complement (GPC). Untreated cells exhibited 
substantial  activity in both  assays.  Neither  antisermn  alone nor complement 
alone  significantly  affected  these  results.  However  pretreatment  with  both 
antiserum  and  complement  essentially  completely  abolished  both  cytotoxic 
and  migration  inhibitory  activities  from  the  suspensions.  Additional  experi- 
ments  (data not shown)  also indicated  that  the cytotoxic activity of immune 
PBL  was  similarly  eliminated  by  this  pretreatment.  We  concluded  that  the 
TABLE II 
Effect of Anti-BAO Serum on Effector Cell Activity of 14-Day Immune Spleen Cells in Assays 
of Cytotoxicity and Migration Inhibition 
Pretrcstment  Spccitic  Migration 
of ceils*  ~ x  Cr relcase~  inhibition§ 
%  % 
None  76 4-  2.0  35  4-  12 
Anti-BA0 alone  82  4-  1.3  38  4-  8 
GPC alone  78  4-  1.6  34  4-  8 
Anti-BA8 +  GPC  5 -4- 2.0  6  4-  5 
* Preparation  of antiserum,  specificity tests  and  treatment of cells with  antiserum  and 
complement are described in Materials and Methods. 
:~ Mean % specific SlCr release 4- 1 SEM (triplicate determinations).  After each of indi. 
cated pretreatments,  cells were resuspended so that  each well contained  7.5  X  108 viable 
immune spleen cells (effector: target cell ratio, 150:1). 
§ Mean % migration inhibition -4- 95% confidence limits (quadruplicate  determinations). 
After each of indicated  pretreatments,  cells were resuspended so that each capillary  tube 
contained 8 X  105 viable immune spleen cells, 1 ×  106 C57BL macrophages and  either 4  X 
105 irradiated BALB/c spleen cells or 4 ×  10  s irradiated  C57BL spleen cells. 
cytotoxic  and  macrophage  migration  inhibition  assays  in  the  present  model 
were indeed both primarily assays of T-cell-mediated immune reactions. 
Velocity  Sedimentation  Profiles  of  Immune  Spleen  and PLN  Cells  Active  in 
Cytotoxicity  and Migration Inhibition.--The  next experiments were carried out 
to investigate  whether  the  T  cells  mediating  these  two  reactions might  have 
distinctive  physical  properties  in  addition  to  the  distinctive  in  vivo  charac- 
teristics  described  above.  To  do  this  we  utilized  the  technique  of  velocity 
sedimentation,  which separates cells principally on the basis of size (22). 14-day 
immune spleen or PLN cells were sedimented  at  1 g for 3  h  at 4°C through a 
buffered step BSA gradient.  Fractions were collected, washed and resuspended 
to equal  volumes.  The  two upper panels  in  Fig.  4  (a and  b)  show the viable 
nucleated  cell profiles for these velocity sedimented  immune spleen  and PLN 
cells, each exhibiting the expected peak of cells sedimenting at about 3 ram/h, 
and  rapidly falling off,  with  only about  5 %  of the  cells  sedimenting  at  more 0 
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Fro. 4.  Velocity sedimentation properties of immune spleen and PLN cells active in cyto- 
toxicity and macrophage migration inhibition. Spleen and PLN  cells obtained from C57BL 
mice 14 days after i.p. inoculation with 107 P815X2 cells. Both populations subjected to veloc- 
ity sedimentation (see Materials and Methods for details) for 3 h at 4°C.  Panels a and b show 
the sedimentation profiles of viable nucleated cells from spleen and PLN, respectively. The 
fractions were each resuspended to equal volumes, and constant percentages of each fraction 
then tested /or  their capacity  to lyse  51Cr-labeled  P815X2 cells and  to inhibit macrophage 
migration. Panels c and d show results of cytotoxicity assay using velocity sedimented spleen 
(e) and PLN (&) cells.  Data points are means (-I-1 SEM) of triplicate determinations, each 
well containing S X  104 target cells and 10% of the cells from a given fraction. Data points at 
far left of panels c and d show the mean %  specific  lysis of these targets by 5  X  106 unfrac- 
tionated immune spleen ceils and 1.25  X  107 unfractionated immune PLN cells,  respectively. 
Panels e and ]  show the migration inhibition activity of velocity sedimented spleen (e)  and 
PLN  (A) cells. Data points are means (4-95% confidence limits) of quadruplicate determina- 
tion, each capillary tube containing 106 macrophages,  1% of the cells contained in a  given 
fraction, and 4 X  105 irradiated BALB/c spleen cells as antigen. Data points at far left of each 
panel indicate the inhibition seen with 8  X  105 unfractionated immune cells/tube in the pres- 
ence of either 4  X  105 irradiated BALB/c spleen cells (closed  symbols) or irradiated C57BL 
spleen cells (open symbols). 
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than 6 mm/h. Constant percentages of each fraction were then tested in parallel 
in either the cytotoxicity or migration inhibition assays. 
The left half of Fig. 4 depicts the results obtained with fractionated immune 
spleen cells. Panel c shows that the majority of 14 day splenic cytotoxic activity 
was associated with cells which sedimented at less than 4 mm/h; on the other 
hand,  as  shown  in panel  e,  virtually all  of the  antigen-stinmlated  migration 
inhibition activity localized with cells sedimenting at more than 4 mm/h. The 
right half of Fig. 4 shows that very similar results were obtained with velocity- 
sedimented immune PLN cells.  What  little cytotoxic activity was present in 
PLN cells was found to sediment with the cells having sedimentation velocities 
of 4.5 mm/h or less while the macrophage migration inhibition activity was all 
found in fractions containing cells which sedimented at >  4.5 mm/h. The use 
of such activity profiles to analyze the sedimentation velocities of cells with a 
given effector function is valid only if the linear dilution curves for the various 
fractions do not have grossly disparate slopes (i.e., plots of effector activity as 
a  function  of  the  number  of  immune  cells).  This  was  confirmed  (data  not 
shown) for cytotoxicity in all experiments. Thus although for convenience the 
data points shown in Fig. 4 were those obtained with a single dilution of effector 
cells, all fractions were tested at at least three separate dilutions; plotting this 
data as  % specific lysis versus the log of the number of  immune  fractionated 
cells yielded a series of straight and relatively parallel lines. 
These experiments showed that under the conditions employed  one could 
achieve at least partial  separation of immune T  cells  mediating either cyto- 
toxicity or macrophage  migration  inhibition  on  the  basis  of  cell  size;  when 
tested  directly after velocity sedimentation  cytotoxic activity  localized pre- 
dominantly  with  small  lymphocyte-enriched fractions whereas  migration  in- 
hibition  activity  localized  predominantly  in  fractions  enriched  with  larger 
lymphocytes. 
Velocity Sedimentation  Profile of Splenic  Progenitors of Cells Active in Cyto- 
toxicity  and Migration  Inhibition.--The  previous experiments had each given 
results compatible with the h)"pothesis that the T  effector cells for cytotoxicity 
and macrophage migration inhibition belonged to different subpopulations of 
activated T  cells.  If this were so,  then these subpopulations could have been 
generated either from a  common precursor population  or alternatively from 
distinct subpopulations of precursor cells. An important additional question in 
this latter case is at what point in time and  space does  this commitment to a 
given function take place? In a preliminary attempt to approach this question 
we asked whether thexe was any difference between the velocity sedimentation 
profile of the splenic precursors of cytotoxic lymphocytes and the profile of the 
splenic precursors of migration inhibitory lymphocytes. Accordingly, normal 
C57BL spleen cells  were subjected  to velocity sedimentation for 4  h  at 4°C. 
The time of sedimentation was increased in these experiments in order to allow 
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in sedimentation rates. The fractions collected are shown in the top panel of 
Fig.  5.  Multiple  cultures  of each  fraction were  then  set  up  as  described in 
Materials  and Methods with  7  X  106 fractionated spleen cells and 3  X  106 
irradiated  BALB/c spleen cells as antigen.  The number of cultures initiated 
for any fraction was of course limited by the number of cells in that fraction. 
After 5 days the cultures were harvested, those from a  given fraction pooled 
and  washed  once;  all  groups  were  then  resuspended  in  similar  volumes  of 
DF10.  Constant aliquots from each of the cultured fractions were then tested 
in parallel for either their capacity to lyse 5~Cr-labeled P815X2 cells (Fig. 5 b) 
or to inhibit macrophage migration in the presence of specific antigen (Fig. 5 c). 
It can be seen that while the sedimentation profiles for the precursors of these 
two effector activities were rather similar,  they however were not coincident. 
The cytotoxicity profile showed peak activity generated from cells sedimenting 
at about 3.2 mm/h, while the activity profile for migration inhibition showed 
maximum activity generated not in this fraction but from slightly larger  cells. 
If the precursors of the cells active in cytotoxicity and migration inhibition were 
identical  then  one  might  have  expected  the  same  fraction  to  generate  the 
highest level of activity in each of the assays. This has not been the case; the 
finding  of nonidentical  fractions generating peak  activity in  the  two  assays 
has been a reproducible one. The results shown in Fig. 5 are therefore consistent 
with  the  hypothesis  that  cytotoxic and  migration  inhibition  activities  are 
generated from different precursor populations. 
DISCUSSION 
The cell-mediated immune response of mice after injection of allogeneic cells 
is characterized by the development of activated T  cells specifically reactive 
toward those alloantigens. This T-cell activation can be measured in a variety 
of assay systems. One of the most extensively used assays has been the measure- 
ment  of  an  activated  population's  capacity  to  specifically lyse  homologous 
alloantigen-bearing cells in vitro. Another activity which  can be quantitated 
is the capacity of immune cells in the presence of specific antigen to inhibit the 
in vitro migration of normal macrophages. The present study has investigated 
some of the physical and biological properties of the cells involved in mediating 
these two effector activities. The results of this investigation indicate that these 
two effector activities are indeed mediated by T cells, and that there are several 
experimental situations in which cytotoxic and macrophage migration inhibi- 
tion activities are to a  large degree dissociable, suggesting that different cells 
mediate these activities. 
The first indication that cytotoxicity and migration inhibition were not in- 
variably associated with each other came from the  studies of the  tissue dis- 
tributions of these activities in  animals  immunized i.p.  with  the  tumor allo- 
graft. Early studies by Brunner et al (26) had indicated that at the peak of the 
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Fro. 5.  Velocity sedimentation profile of the progenitors from normal  C57BL  spleens of 
cells active in cytotoxicity and macrophage migration inhibition following in vitro sensitization 
to alloanfigen. Panel a  shows the viable nucleated cell profile for normal C57BL  spleen cells 
after sedimentation for 4 h at 4°C. Each fraction, as well as an aliquot of unfractionated cells, 
was placed in culture in the presence of irradiated BALB/c spleen cells under conditions de- 
scribed in detail in Materials and Methods. After 5 days the multiple cultures of each fraction 
were harvested and pooled, and then each fraction was resuspended to an equal volume. The 
fractions were then each tested in parallel for both their capacity to lyse 51Cr-labeled  target 
cells and to inhibit macrophage migration in the presence of appropriate alloantigen. The same 
percentage of the cells from each fraction was analyzed in either of the in vitro assays. Panel b 
shows the activity profile of progenitors of cytotoxic cells. Data points are means (4-1 SEM) 
of triplicate determinations. Each well contained 5  X  104 target cells and 6% of the cells in a 
given fraction. Panel c shows the activity profile of progenitors of cells active in inhibiting 
macrophage  migration.  Data  points are  means  (4-95%  confidence limits)  of quadruplicate 
determinations. Each capillary tube contained 10  ~ macrophages, 4  X  105 irradiated BALB/c 
spleen cells and  1% of the cells from a  given fraction. Data points at far left of panel show 
migration inhibition seen with sensitized unfractionated cells in the presence of either irradiated 
BALB/c spleen cells (closed circle) or irradiated C57BL spleen cells (open circle). ROBERT  E.  TIGELAAR  AND  R.  M.  GORCZYNSKI  283 
levels of cytotoxicity were demonstrable in PBL, spleen,  and MLN cell sus- 
pensions; these observations were confirmed in the present study. In addition, 
however,  we  observed  that  the  peripheral,  presumably  nondraining  lymph 
nodes from these mice displayed very little cytotoxic activity. This  lack of 
cytotoxic activity could not readily be explained by the presence of an over- 
riding concurrent suppressive activity in these suspensions. That PLN indeed 
contained  substantial  numbers  of  precursors  of  cytotoxic cells  was  demon- 
strated  in  the  experiment where following subcutaneous immunization with 
the tumor allograft very respectable levels of cytotoxic activity were found in 
PLN  suspensions.  In  this  case,  however,  the  MLN  suspension  (which were 
now presumably the distal nondraining nodes) were devoid of substantial cyto- 
toxic activity. With either i.p. or subcutaneous immunization, PBL suspensions 
were  cytolytic, suggesting that  cytotoxic T  cells  could  enter  the blood but 
once having gotten there were somehow deficient in their capacity to traverse 
the postcapillary venular endothelium and enter or re-enter lymph node tissue 
(31). 
On the other hand, when the PLN cells from i.p. immunized mice were tested 
for their capacity to specifically inhibit migration of normal mouse peritoneal 
macrophages they were found to be at least as active as the spleen cells from 
these same animals. This dissociation first suggested that distinct subpopula- 
tions of T  cells could be mediating cytotoxicity and migration inhibition. 
The  adoptive  transfer  of  immune spleen  cells  into  lethally irradiated  re- 
cipients provided additional support for the above hypothesis. Upon adoptive 
transfer of such cells  into irradiated syngeneic recipients,  significantly more 
macrophage migration inl~ibition  activity (on a  cell for cell basis)  was found 
24 h  later in the lymph node-seeking population than in  the  spleen-seeking 
population. On the other hand cytotoxic activity was much more evident in 
recipient  spleen  cell  suspensions  than  in  PLN  suspensions.  It  is  generally 
accepted that one of the characteristics of recirculating lymphocytes is their 
capacity  to  migrate  to  lymph nodes in  such  adoptive  transfer  experiments 
(37, 48).  Recent studies have pointed out that antigen can cause a  transient 
nonspecific trapping of recirculating lymphocytes at the site of antigen localiza- 
tion (49-51).  It is possible that the immune spleen cell suspension contained 
significant amounts of alloantigen, and that upon  i.v.  transfer of  these  sus- 
pensions such an antigen trap was operative in the recipient spleen.  It could 
be argued that this was at least a  partial explanation for the localization of 
cytotoxic activity in the spleen; nevertheless, this still would not explain the 
disparate patterns of localization for cytotoxic activity on the one hand and 
migration inhibition activity on the other. 
The third series  of experiments which support  the possibility that distinct 
subpopulations o[ T  cells are involved in cytotoxicity and migration inhibition 
were those employing 1 g velocity sedimentation to fractionate immune cells 
immediately before  testing  for  these  effector  activities.  Essentially  similar 
results were obtained with either immune spleen or PLN cells. The majority 284  SUBPOPULATIONS  OF  ACTIVATED MURINE  T  LYMPHOCYTES 
of cytotoxic activity was found with  ceils  sedimenting  at  about 4  mm/h  or 
less; on the other hand  the majority of macrophage migration inhibition ac- 
tivity was observed with cells sedimenting at more than 4 mm/h. 
Several points  concerning this  segregation  of activities  warrant  comment. 
First of all,  the separation of cytotoxic and migration inhibition activities was 
not absolute; though the majority of cytotoxic activity was present in smaller 
cells, fractions enriched for larger cells were not devoid of this activity. Indeed, 
on a cell for cell basis the large lymphocytes are more active than the smaller 
lymphocytes, but because such large cells make up only a small percentage of 
such immune populations their contribution to the total cytotoxic activity is 
rather  meager.  Furthermore if one looks at  the  activity profiles of velocity 
sedimented ceils obtained either from spleens 8 days after in vivo immuniza- 
tion (instead of 14 days) or 5 days after in vitro sensitization these profiles are 
definitely shifted  toward  larger  cells  (30,  and  R.  Tigelaar,  unpublished  ob- 
servations). 
While very substantial  amounts of cytotoxic activity were always seen  in 
small lymphocyte-enriched fractions, virtually no migration inhibition activity 
was  ever seen  when such  cells  were tested immediately after sedimentation, 
suggesting a  rather complete separation of activities in these fractions. More 
recent experiments, however, which will be the subject of a separate communi- 
cation, have indicated  that  the lack of migration inhibition activity in  these 
fractions also  is not  absolute, since appropriate manipulation  of this popula- 
tion  (such  as  either  overnight  incubation,  mild  trypsinization,  or  adoptive 
transfer into irradiated recipients) leads to significant activity in small lympho- 
cyte-enriched fractions when they were subsequently retested. 
We  have  demonstrated  a  gross  separation  of T-celt-mediated alloantigen- 
directed cytotoxicity from macrophage migration inhibition in three types of 
experiments, and in so doing add to the ever-growing list of murine T-cell func- 
tions  which  can  be dissociated from each  other  (52-62).  These dissociations 
can be explained by the existence of distinct subpopulations of T  cells with 
discrete and  limited functional  capabilities.  Since none of the manipulations 
used in these experiments resulted in populations completely devoid of either 
cytotoxic or  migration  inhibition  activity,  the  present  experiments  do  not 
permit a categorical statement that a given subpopulation of T  cells has only 
one or the other of these particular effector functions. While this has certainly 
not been excluded, several other possibilities come to mind. Some activated T 
cells may express both functions and others only one. It is also possible that 
during  antigen-stimulated  proliferations  and  differentiation,  expression  of  a 
given effector activity is a function of the cell cycle: i.e., at a given point in the 
cell  cycle one effector activity is either preferentially expressed (or preferen- 
tially suppressed or rendered capable of being suppressed) in relation to another 
activity. For example: certain cultured cell lines have been shown to selectively 
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The relationship of the ceils involved in the functions studied here to those 
in other assays of T-cell responsiveness has not been fully investigated. It is 
worth reiterating  the  observations of Grant  et al  (61),  who noted no direct 
cytotoxicity but  substantial  antigen-specific  macrophage  arming  activity in 
suspensions  of  thymocytes from  i.p.  tumor  allografted mice,  although  both 
activities were present in spleen suspensions from these mice. This appears to 
be rather similar to the dissociation we observed between immune spleen cells 
(good activity in both assays) and immune PLN cells (good activity in migra- 
tion inhibition assay, little activity in cytotoxicity assay). Dr. G. M. Iverson, 
utilizing the identical experimental model, has observed that on a cell for cell 
basis immune PLN cells are as active as immune spleen cells in their capacity 
to release specific macrophage  arming factor  (SMAF)  (personal communica- 
tion); it is very possible that the same cell type is responsible for SMAF release 
and inhibiting macrophage migration. 
It is probable that with regard to effector functions a single antigen-activated 
T  cell  has  a  limited  repertoire and  perhaps  is  even  restricted  to  playing  a 
single tune.  A  crucial  question is at what point  does this  commitment  take 
place?  In  an  attempt  to  approach  this problem we  asked  the perhaps naive 
question of whether there was any difference between the velocity sedimenta- 
tion profile of the splenic precursors of cytotoxic lymphocytes and the profile 
of the splenic precursors of cells capable of inhibiting macrophage migration. 
The experiments represented in Fig. 5 would indicate that there may be such 
a difference. The fraction of normal spleen cells which after in vitro sensitiza- 
tion showed the most cytotoxic activity did not exhibit the  maximum  migra- 
tion inhibition activity. If there was a common splenic precursor cell for these 
effector activities, one might have expected the  activity profiles to be  coin- 
cident. Thus it is possible that in the spleen of a nondeliberately  alloantigen- 
stimulated  adult  animal  commitment  to  either of  these  particular  effector 
functions has  already taken place.  However it must  also be considered that 
this commitment may not occur until a  common  multipotential  splenic pre- 
cursor cell confronts antigen,  and  that  the particular effector activity which 
this cell can express is determined by the precise conditions under which the 
antigen is confronted. This in turn could be influenced by a number of other 
factors  including  the  presence  or  quantity  of  any  other  cell  or  cells  which 
could exert some type of regulatory influence on the differentiating T  cell. 
SUMMARY 
The immune response of C57BL mice to a DBA/2 tumor allograft has been 
assessed  in  two  assays  of cell-mediated immunity,  the  in vitro lysis of 51Cr- 
labeled target cells and the antigen-mediated inhibition of macrophage migra- 
tion.  Both  assays  were  shown  to  be  measuring  a  T-cell-mediated  reaction. 
Three types of experiments suggested that  distinct subpopulations of T  cells 
mediate  these  reactions. The tissue  distributions  of these  activities was dis- 286  SUBPOPULATIONS  OF  ACTIVATED  MURINE  T  LYMPHOCYTES 
tinctive;  both  activities  were  present  in  spleens  from  i.p.  immunized  mice, 
but only macrophage migration inhibition activity was found in the peripheral 
lymph nodes  (PLN)  of such  mice. Adoptive  transfer of immune spleen  cells 
into irradiated  syngeneic recipients revealed that while  a  substantial  amount 
of migration inhibition activity could subsequently be found in PLN, eytotoxic 
activity  was  found  predominantly  in  the  spleens  of  these  adoptive  hosts. 
Velocity sedimentation analysis of immune cells  14 days after i.p.  immuniza- 
tion  indicated  that  while  the  majority  of  cytotoxic  activity  was  associated 
with  small  and  medium  lymphocytes,  the  majority  of  migration  inhibition 
activity  was  associated  with  medium  and  large  lymphocytes.  In  addition, 
normal  spleen  cells were Iractionated by velocity sedimentation  immediately 
before allosensitization in vitro. Subsequent analysis of the sensitized fractions 
revealed that  the activity profiles for cytotoxicity and macrophage migration 
inhibition were not coincident.  The implications of these observations are dis- 
cussed. 
The authors would like to express their appreciation to Prof. N. A. Mitchison for his sup- 
port throughout the course of these studies and to Dr. Richard Asofsky for his helpful com- 
ments during the preparation of this manuscript. 
REFERENCES 
1.  Warner, N. L., A. Szenberg,  and F. M. Burnet.  1962. The immunologic  role of 
different  lymphoid  organs in  the  chicken.  I.  Dissociation  of  immunological 
responsiveness.  Aust. J. Exp. Biol. Med. Sci. 40:373. 
2.  Good, R. A., and A. E. Gabrielsen.  1968. The thymus and other lymphoid organs 
in  the  development of the  immune  system. In  Human Transplantation.  F. 
Rapaport and J. Dausset, editors.  Grune and Stratton, Inc., New York. 526. 
3.  Miller, J. F. A. P., and G. F. Mitchell.  1969. Thymus and antigen reactive cells. 
Transplant. Rev. 1:3. 
4.  Davies, A. J. S. 1969. "Ihe thymus and the cellular basis of immunity. Transplant. 
Rev. 1:43. 
5.  Claman, N. H., and  E. A.  Chaperon.  1969. Immunologic complementation be- 
tween thymus and marrow cells--a model for the two-cell theory of immuno- 
competence. Transplant. Rev. 1:92. 
6.  Jerne, N. K., and A. A. Nordin. 1963. Plaque formation in agar by single antibody 
producing cells. Science  (Wash. D. C.). 140:405. 
7.  Cunningham,  A. J.  1965. A method of increased  sensitivity for detecting single 
antibody forming cells. Nature (Lond.). 20"/:1106. 
8.  Nossal,  G. J. V., A. E. Bussard, H. Lewis, and J. C. Mazie.  1970. In vitro stimula- 
tion  of antibody formation by peritoneal  cells.  I. Plaque  technique  of high 
sensitivity enabling access to the cells. J. Exp. Med. 131:894. 
9.  Nossal,  G. J. V., I-I. Lewis,  and N. L. Warner.  1971. Differential sensitivity of 
haemolytic plaque  methods at  various  stages  of  the  immune response.  Cell. 
Immunol. 2:13. 
10.  Nossal,  G. J. V., N. L. Warner, and H. Lewis. 1971. Incidence of cells simultane- 
ously secreting IgM and IgG antibody to sheep  erythrocytes. Cell. Immunol. 
2:41. ROBERT E.  TIGELAAR AND R.  M.  GORCZYNSKI  287 
11.  Nordin, A. A., H. Cosenza, and S. Sell.  1970. Immunoglobulin class of antibody- 
forming cells in mice. 2I. Class restriction of plaque-forming cells demonstrated 
by replica plating. J. Immunol. 104:495. 
12.  Merchant, B., and Z. Brahmi.  1970. Duplicate plating of immune cells products: 
analysis of globulin class secretion by single cells. Science (Wash. D. C.). 16'/:69. 
13.  Miller,  H. C., and  G. Cudkowicz.  1971. Density gradient separation  of marrow 
cells restricted for antibody class.  Science (Wash. D. C.). 171:913. 
14.  M~.kel~t, O., and A. M. Cross. 1970. The diversity and specialization of immuno- 
cytes. Prog. Allergy. 14:145. 
15.  Boyle, W. 1968. An extension of the 51Cr-release assay for the estimation of mouse 
cytotoxins. Transplantation. 6:761. 
16.  Gorczynski, R. M.,  R. G. Miller,  and R. A. Phillips.  1973. Reconstitution of T 
cell-depleted  spleen  cell populations by factors derived from T  cells. 2. Condi- 
tions for the production of active T  cell supernatants. J. Immunol.  110:968. 
17.  Golub, E.  1971. Brain-associated ~ antigen: reactivity of rabbit anti-mouse brain 
with mouse lymphoid cells. Cell. Immunol. 2:353. 
18.  Gorczynski, R. M.  1974. Evidence for in vivo protection against routine-sarcoma 
virus-induced  tumors by T  lymphocytes from immune animals.  J. Immunol. 
112:533. 
19.  Raft,  M.  C.  1970. Two distinct  populations  of peripheral  lymphocytes in mice 
distinguishable by immunofluorescence. Immunology. 19:637. 
20.  Greaves, M. F., and G. Janossy. 1972. Elicitation of selective T and B lymphocyte 
responses by cell surface binding ligands. Transplant. Rev. 11:87. 
21.  Feldmann, M., and A. J. Basten.  1971. The relationship between antigenic struc- 
ture and the requirement for thymus-derived cells in the immune response. J. 
Exp. Med. 134:103. 
22.  Miller, R. G., and R. A. Phillips.  1969. Separation of cells by velocity sedimenta- 
tion. J. Cell. Physiol. 73:191. 
23.  Miller,  R. G., and R. A. Phillips.  1970. Sedimentation analysis of the cells in mice 
required  to initiate  an in vivo immune response  to sheep erythrocytes. Proc. 
Soc. Exp. Biol. Med. 135:63. 
24.  Dunn, T. B., and  M. Potter.  1957. A  transplantable  mast-cell neoplasm in the 
mouse. J. Natl. Cancer Inst. 18:587. 
25.  Gofer, P. A. 1956. Some recent work on tumor immunity. Adv. Cancer Res. 4:149. 
26.  Brunner,  K. T., J. Mauel, H. Rudolf, and B. Chapius.  1970. Studies of allograft 
immunity  in  mice.  I.  Induction,  development  and  in  vitro  assay  of cellular 
immunity. Immunology. 18:501. 
27.  David, J.  R.,  S.  A1-Askari,  H.  S.  Lawrence, and J.  L. Thomas.  1964. Delayed 
hypersensitivity in vitro.  I. The  specificity of inhibition  of cell  migration by 
antigens. J. Immunol. 93:264. 
28.  Canty, T., J. R. Wunderlich, and F. Fletcher.  1971. Qualitative and quantitative 
studies of cytotoxic immune cells. J. Immunol. 106:200. 
29.  Wagner, H.,  and  M.  Feldmann.  1972. Cell-mediated  immune  response in vitro. 
2. A  new system for the generation  of cell-mediated  cytotoxic activity.  Cell. 
Immunol. 3:405. 
30.  MacDonald, H. R., R. A. Phillips,  and R.  G. Miller.  1973. Allograft immunity 
in the mouse.  I.  Quantitation  and  specificity of cytotoxic effector cells  after 
in vitro sensitization. J. Immunol. 111:565. 288  SUBPOPULATIONS  OF  ACTIVATED MURINE T  LYMPHOCYTES 
31.  Gowans, J. L., and E. J. Knight. 1964. The route of recirculation of lymphocytes 
in the rat. Prec. R. Soc. Lond. B. Biol. Sci. 159:257. 
32.  Canty, T. G., and J. R. Wunderlich.  1970. Quantitative in vitro assay of cellular 
cytotoxic immunity. J. Natl. Cancer Inst. 45:761. 
33.  Brunner,  K.  T.,  and  J.  C.  Cerottini.  1971. Cytotoxic lymphocytes as  effector 
cells of cell-mediated immunity. In Progress in Immunology. B. Amos, editor. 
Academic Press, Inc., New York. 385. 
34.  H/iyry, P. L., L. C. Andersson, S. Nordling, and M. Virolainen.  1972. Allograft 
response in vitro.  Transplant. Rev. 12:91. 
35.  Gorczynski, R. M.  1974. Immunity to routine-sarcoma virus-induced tumors. I. 
Specific T lymphocytes active in macrophage migration inhibition and lympho- 
cyte transformation. J. Immunol. 112:1815. 
36.  Gorczynski, R. M.  1974. Immunity to routine-sarcoma virus-induced tumors. II. 
Suppression of T  cell-mediated immunity by ceils from progressor animals. J. 
Immunol. 112:1826. 
37.  Lance,  E.  M.,  and  Taub,  R.  N.  1969. Segregation of lymphocyte populations 
through differential migration. Nature (Lond.). 221:841. 
38.  Morse, H. C., III, and R. Asofsky. 1974. In vivo effects  of antithymocyte serum 
on  the  homing  patterns  and  graft-versus-host  reactivity  of  murine  splenic 
lymphocytes. Cell. Immunol. 11:13. 
39.  Cerottini,  J.  C.,  A.  A. Nordin,  and  K. T.  Brunner.  1970. In  vitro  cytotoxicity 
of thymus cells sensitized to alloantigens. Nature (Lond.). 227:72. 
40.  Wagner,  H.,  A.  W.  Harris,  and  M.  Feldmann.  1972. Cell-mediated  immune 
response  in  vitro.  II. The  role  of thymus and  thymus-derived  lymphocytes. 
Cell. Immunol. 4:39. 
41.  Evans, R., and P. Alexander. 1972. Mechanism of immunologically specific killing 
of tumor ceils by macrophages. Nature (Lond.). 236:170. 
42.  Evans, R., and P. Alexander. 1972. Role of macrophages in tumor immunity.  III 
Cooperation between macrophages and lymphoid factors in an in vitro allograft 
situation. Immunology. 23:677. 
43.  Lohmann-Matthes,  M.  D.,  H.  Schipper,  and  H.  Fischer.  1972. Macrophage- 
mediated cytotoxicity against allogeneic  target cells in vitro. Eur. J. Immunol. 
2:45. 
44.  MacLennon, I. C. M., G. Loewi, and A. Howard. 1969. A human serum immuno- 
globulin  with  specificity  for  certain  homologous target  cells,  which  induces 
target cell damage by normal human lymphocytes. Immunology.  1'/:897. 
45.  Rosenstreich, D. L., J. T. Blake, and A. S. Rosenthal. 1971. The peritoneal exudate 
lymphocyte. I. Differences in antigen responsiveness between peritoneal exudate 
and  lymph  node  lymphocytes from  immunized  guinea  pigs.  J.  Exp.  Med. 
134:1170. 
46.  Rosenthal, A. S., J. M. Davie, D. L. Rosenstreich, and J. T. Blake.  1972. Deple- 
tion  of antibody-forming cells  and  their  precursors  from  complex lymphoid 
cell populations. J. Immunol. 108:279. 
47.  Yoshida,  T.,  H.  Souozaki,  and  S.  Cohen.  1973.  The  production  of migration 
inhibition factor by B and T  cells of the guinea pig. J. Exp. Med. 138:784. 
48.  Taub, R. N., and E. M. Lance. 1971. Effects of lymphoic depletion on the distribu- 
tion of 51Cr-labelled lymph node cells in mice.  Transplantation.  11:536. ROBERT E.  TIGELAAR AND R.  M.  GORCZYNSKI  289 
49.  Zatz, M., and E. M. Lance. 1971. The distribution of 51Cr-labelled lymphocytes 
into antigen-stimulated  mice. Lymphocyte trapping.  J. Exp. Med. 134:224. 
50.  Zatz, M.,  and E.  M. Lance.  1971. Lymphocyte trapping  in tolerant mice. Nat. 
New Biol. 9.34:253. 
51.  Frost, P., and E. M. Lance. 1973. Abrogation of lymphocyte trapping by ascitic 
turnouts. Nature (Lond.). 246:101. 
52.  Asofsky, R.,  R. Tigelaar,  and  H.  Cantor.  1971. Cell  interactions  in the graft- 
versus-host response. In Progress in Immunology. B. Amos, editor.  Academic 
Press, Inc., New York. 369. 
53.  Cantor, H., and R. Asofsky. 1972. Synergy among lymphoid cells mediating the 
graft-vs.-host  response.  III.  Evidence  for  interaction  between  two  types  of 
thymus-derived cells. J. Exp. Med. 135:764. 
54.  Tigelaar, R. E., and R. Asofsky. 1973. Synergy among lymphoid cells mediating 
the graft-vs.-host response.  V.  Derivation by migration in lethally  irradiated 
recipients of two interacting subpopulations of thymus-derived cells from normal 
spleen.  J. Exp. Med. 137:239. 
55.  Cohen, L., and M. L. Howe. 1973. Synergism between subpopulations of thymus- 
derived cells mediating the proliferative and effector phases of the mixed lym- 
phocyte reaction. Proc. Natl. Acad. Sci. U. S. A. 70:2707. 
56.  Wagner, H.  1973. Synergy during in vitro cytotoxic allograft responses.  I. Evi- 
dence for cell interaction between thymocytes and peripheral T  cells.  J. Exp. 
Med. 138:1379. 
57.  Tigelaar, R. E., and M. Feldmann. 1973. Synergy among thymocytes and periph- 
eral lymph node cells  in the  in vitro  generation of lymphocytes cytotoxic to 
alloantigens. Transplant. Proc. 5:1711. 
58.  Kano, S., B. R. Bloom, and M. L. Howe. 1973. Enumeration of activated thymus- 
derived lymphocytes by the virus plaque assay. Proc. Natl. Acad. Sci. U. S. A. 
70:2299. 
59.  Stobo, J. D., A. S.  Rosenthal,  and W. E. Paul.  1972. Functional heterogeneity 
of murine  lymphoid cells.  I.  Responsiveness  to  and  surface  binding  of con- 
canavalin A and phytohemagglutinin. J. Immunol. 108:1. 
60.  Stobo, J. D., and W. E. Paul. 1973. Functional heterogeneity of routine lymphoid 
cells.  III. Differential  responsiveness  of  T  cells  to  phytohemagglutinin  and 
concanavalin A as a probe for T  cell subsets. J. Immunol.  110:362. 
61.  Grant,  C. K., G. A. Currie, and P. Alexander.  1972. Thymocytes from mice im- 
munized against  an allograft render  bone-marrow cells  specifically cytotoxic. 
J. Exp. Med. 135:150. 
62.  Gordon, J., and H. Yu.  1973. Relationship  of T  cells involved in cell mediated 
immunity and antibody synthesis. Nat. New Biol. 244:21. 
63.  Tubergen, D. G., J. D. Feldman, E. M. Pollack, and R. A. Lerner. 1972. Produc- 
tion  of macrophage  migration  inhibition  factor  by  continuous  cell  lines.  J. 
Exp. Med. 135:255. 